Spain
Tuberculosis profile
Population  2013 47 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.24 (0.23–0.24) 0.51 (0.5–0.51)
Mortality (HIV+TB only) 0.049 (0.023–0.085) 0.1 (0.05–0.18)
Prevalence  (includes HIV+TB) 7.3 (3.1–13) 16 (6.5–28)
Incidence  (includes HIV+TB) 6.1 (5.8–6.8) 13 (12–15)
Incidence (HIV+TB only) 0.53 (0.39–0.67) 1.1 (0.83–1.4)
Case detection, all forms (%) 86 (77–90)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 0.22 (0.03–0.8) 7.1 (3.3–13)
MDR-TB cases among notified pulmonary
TB cases
8 (1–30) 21 (10–39)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 3 042   0
Pulmonary, clinically diagnosed 719   0
Extrapulmonary 1 483   0
       
Total new and relapse 5 244    
Previously treated, excluding relapses 295    
Total cases notified 5 539    
Among 5 233 new and relapse cases:
377 (7%) cases aged under 15 years; male:female ratio: 1.5
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 1 458 (48%) 103 (35%) 1 561
Laboratory-confirmed RR-/MDR-TB cases     42
Patients started on MDR-TB treatment      
TB/HIV 2013 Number (%)
TB patients with known HIV status 4 065 (73)
HIV-positive TB patients 273 (7)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 71
Previously treated cases, excluding relapse, registered in 2012 60
HIV-positive TB cases, all types, registered in 2012 60
RR-/MDR-TB cases started on second-line treatment in 2011  
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-07-01 Data: www.who.int/tb/data